On December $31,2023,$ before the books were closed, management and the accountant at Blossom Inc. made the following

determinations about three depreciable assets:

Depreciable asset $A($building$)$ was purchased on January $2,2020.$ It originally cost $$545,000$ and the straight$-$line method

was chosen for depreciation. The asset was originally expected to be useful for $10$ years and have no residual value. In $2023,$

the decision was made to change the depreciation method from straight$-$line to double$-$declining$-$balance due to a change in

the pattern of benefits received. The estimates relating to useful life and residual value remained unchanged.

Depreciable asset $B($machinery$)$ was purchased on January $3,2019.$ It originally cost $$207,000$ and the straight$-$line method

was chosen for depreciation. The asset was expected to be useful for $15$ years and have no residual value. In $2023,$ the

decision was made to shorten this asset's total life to nine years and to estimate the residual value at $$3,500.$

Depreciable asset $C($equipment$)$ was purchased on January $5,2019.$ The asset's original cost was $$160,000$ and this amount

was entirely expensed in $2019$ in error. This particular asset has a $10-$year useful life and no residual value. The straight$-$line

method is appropriate.

The accountant mentioned that the corporation was experiencing a higher than expected number of bad debt write$-$offs in the current

year. For this reason, the bad debts percentage of accounts receivable used in the year$-$end adjustment was changed from $6\mathrm{.}5\%$ to $8\%.$

The loss on impairment for the current year was calculated using the new rate of $8\%.$ The controller estimates that, if the new rate had

been used in the past, an additional $$15,000$ worth of bad debts would have been recorded.

Additional information:

Income in $2023$ before depreciation expense amounted to $$415,000.$

Depreciation expense on assets other than A$,$ B$,$ and C totalled $$68,700$ in $2023.$

Income in $2022$ was reported at $$374,000.$

In both $2022$ and $2023,100,000$ common shares were outstanding. No dividends were declared in either year.

Blossom follows IFRS.

Answer the following questions, ignoring all income tax effects:

$($a$)$

Prepare any necessary entries in $2023.($List all debit entries before credit entries. Credit account titles are automatically indented when

the amount is entered. Do not indent manually. If no entry is required, select $"$No Entry" for the account titles and enter $0$ for the amounts.

Round answers to $0$ decimal places, eg$.5,275.$ Round the rate of depreciation under double$-$declining$-$balance method to $1$ decimal place,

ie$.13\mathrm{.}3\%)$